- Scientific Director, Montreal Cancer Institute
- Director, FRQS Cancer Research Network
A molecular biologist renowned for her work in fundamental and translational research in cancerology. Dr. Mes-Masson’s works focus on the development of cancer models and the identification of molecular events associated with the cancer. Dr. Anne-Marie Mes-Masson uses cutting-edge genomic technologies to determine the characteristics of the molecular events associated with certain cancers. She is also a pioneer in tumour banking practices, including the breast cancer bank supported by the Quebec Breast Cancer Foundation. She also developed expertise in molecular pathology and the use of bio-banked specimens to probe the importance of various biomarkers.
Why Choosing Breast Cancer?
Dr. Mes-Masson has developed key partnerships in the field of hereditary cancers, including breast cancer.
A Scientific Accomplishment You Are Proud of
"Regarding scientific breakthroughs, I am proud to have contributed to the works that made it possible to identify mutations in the BRCA1/BRCA2 genes that are peculiar to French-Canadian families. My contribution was essential to the efforts of the Cancer Network, and its partner the QBCF, in mobilizing the four faculties of medicine in Quebec to achieve a unified collective strategy for bio-banking breast cancer specimens used in research.”
Field(s) of Research
- Cancer biology
- Etiology (causes)
- Screening, diagnosis or prognosis
- Development of scientific models
2013 – The Karen Campbell National Award for Research Excellence
Projects Funded by the Foundation
2011 – Tissue and data bank – Cancer Research Network
2014 – The Quebec Breast Cancer Foundation Tissue Microarrays Consortium for the Evaluation of biomarkers